Work

Local consolidative therapy (LCT) to improve progression-free survival (PFS) in patients with oligometastatic non-small cell lung cancer (NSCLC) who receive induction systemic therapy (IST): Results of a multi-institutional phase II randomized study.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.9004

Authors: Daniel Richard Gomez, George R. Blumenschein, J. Jack Lee, Mike Hernandez, D. Ross Camidge, Robert Charles Doebele, Laurie E. Gaspar, Don Lynn Gibbons, Jose A. Karam, Brian D. Kavanagh, Ritsuko Komaki, Alexander V. Louie, David A. Palma, Anne S. Tsao, William Nassib William, Jianjun Zhang, Stephen Swisher, John Heymach

Institutions: The University of Texas MD Anderson Cancer Center, University of Colorado Anschutz, University of Colorado Cancer Center, University of Colorado Denver

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2525797360

Cites:

Cited by: 12

Related to: 10